Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities

Small-cell lung cancer (SCLC) is generally considered a 'homogenous' disease, with little documented inter-tumor heterogeneity in treatment guidance or prognosis evaluation. The precise identification of clinically relevant molecular subtypes remains incomplete and their translation into c...

Full description

Bibliographic Details
Published in:Pharmacological Research
Main Authors: Lin Yang, Zicheng Zhang, Jiyan Dong, Yibo Zhang, Zijian Yang, Yiying Guo, Xujie Sun, Junling Li, Puyuan Xing, Jianming Ying, Meng Zhou
Format: Article
Language:English
Published: Elsevier 2023-08-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661823002001